MedTrace Logo

Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa

NCT02793960 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2020-06-16

No results posted yet for this study

Summary

This is a single-center study to investigate the effects of a topical cream on patients 12 years of age and older that have been diagnosed with epidermolysis bullosa.

Conditions

  • Epidermolysis Bullosa

Interventions

DRUG

topical BPM31510 3.0% Cream

Application of drug to lesions of epidermolysis bullosa

Sponsors & Collaborators

  • BPGbio

    collaborator INDUSTRY

  • Shasa Hu

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-10
Primary Completion
2019-08-26
Completion
2019-08-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793960 on ClinicalTrials.gov